Related references
Note: Only part of the references are listed.Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States
Shuhui Lim et al.
ACS CENTRAL SCIENCE (2021)
Engineering subtilisin proteases that specifically degrade active RAS
Yingwei Chen et al.
COMMUNICATIONS BIOLOGY (2021)
Selective and noncovalent targeting of RAS mutants for inhibition and degradation
Kai Wen Teng et al.
NATURE COMMUNICATIONS (2021)
RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines
Caleb K. Stubbs et al.
SCIENTIFIC REPORTS (2021)
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y. Jen et al.
CLINICAL CANCER RESEARCH (2020)
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Christopher Nevala-Plagemann et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The Photorhabdus Virulence Cassettes RRSP-Like Effector Interacts With Cyclin-Dependent Kinase 1 and Causes Mitotic Defects in Mammalian Cells
Xia Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models
Patrick L. Garcia et al.
CANCERS (2020)
Development of Recombinant Immunotoxins for Hairy Cell Leukemia
Robert J. Kreitman et al.
BIOMOLECULES (2020)
An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth
Vania Vidimar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
Nicolas Bery et al.
NATURE COMMUNICATIONS (2020)
Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System
Sascha Roth et al.
CELL CHEMICAL BIOLOGY (2020)
Inducible Degradation of Target Proteins through a Tractable Affinity-Directed Protein Missile System
Luke M. Simpson et al.
CELL CHEMICAL BIOLOGY (2020)
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors
Isabel Romero-Calvo et al.
MOLECULAR CANCER RESEARCH (2019)
RAS in pancreatic cancer
Simone Lanfredini et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Semi-quantitative Determination of Protein Expression Using Immunohistochemistry Staining and Analysis: An Integrated Protocol
Alexandra R. Crowe et al.
BIO-PROTOCOL (2019)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The bacterial Ras/Rap1 site-specific endopeptidase RRSP cleaves Ras through an atypical mechanism to disrupt Ras-ERK signaling
Marco Biancucci et al.
SCIENCE SIGNALING (2018)
Substrate Recognition of MARTX Ras/Rap1-Specific Endopeptidase
Marco Biancucci et al.
BIOCHEMISTRY (2017)
Molecular and Genetic Basis of Pancreatic Carcinogenesis Which Concepts May be Clinically Relevant?
Vincent Bernard et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Site-specific processing of Ras and Rap1 Switch I by a MARTX toxin effector domain
Irena Antic et al.
NATURE COMMUNICATIONS (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia
K. C. Ray et al.
ONCOGENE (2014)
KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance
Umberto Miglio et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
KRAS: feeding pancreatic cancer proliferation
Kirsten L. Bryant et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer
Ronil A. Patel et al.
CANCER RESEARCH (2012)
Pancreatic ductal adenocarcinoma screening: New perspectives
Raffaele Pezzilli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Pancreatic stellate cells: a starring role in normal and diseased pancreas
Minoti V. Apte et al.
FRONTIERS IN PHYSIOLOGY (2012)
Current knowledge on pancreatic cancer
Juan Iovanne et al.
FRONTIERS IN ONCOLOGY (2012)
Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma
H. Miles Prince et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Use of Cytokeratin 19 (CK19) Immunohistochemistry in Lesions of the Pancreas, Gastrointestinal Tract, and Liver
Richa Jain et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
GEFs and GAPs: Critical elements in the control of small G proteins
Johannes L. Bos et al.
CELL (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Genetics and biology of pancreatic ductal adenocarcinoma
Aram F. Hezel et al.
GENES & DEVELOPMENT (2006)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Share Paper
